Atrial Septal Defect Market by Diagnosis (Chest X-ray, Electrocardiogram, Cardiac Catherization, Transesophageal Echocardiography, and Pulse Oximetrey) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

The global atrial septal defect market size is projected to expand a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the wide prevalence of heart diseases, rising disposable income of the population of developing regions, and growing awareness about advanced diagnostics procedures and treatment.

Atrial septal defect (ASD) is an inborn heart defect, in which the proper blood flows is disturbed due to the formation of a hole in the wall between the atria, the upper heart chamber. The atria are portion of the hearts upper chamber and are separated by interatrial septum. When interatrial septum is absent or found defective, the blood from left side directly flows and get mixed with the right side of the oxygen deficient blood of the heart. ASD is very common congenital cardiac diseases and, is generally occurred more to women than men. When a baby is born with the opening of the interatrial septum, it is likely to create a hole in the heart, which is called as ASD.

Long-term ASD causes severe lung and heart damage and the detection of ASD through diagnostics is normally conducted when the baby attains the adulthood. If the defect is small, then it usually does not show any symptoms but it leads to lower the oxygen level in the arterial blood, which is supplied to different organs such as tissues and brain. At the time of fetus development, the interatrial septum is developed for separation of left and right atria and a hole is present in the interatrial septum that is known as foremen ovale or foremen septum. During fetal development, the blood movement from right atrium to left atrium is allowed by foremen ovale. This opening helps fetus to bypass the fetal lungs which are nonfunctional to get oxygen from placenta.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing prevalence of heart disorders and diseases among a large number of population especially in Asia Pacific is projected to drive the market growth during the forecast period.
•  Several governments’ initiatives and policies encouraging drug development and advanced diagnostics devices to offer effective treatment of ASD are likely to propel the market growth.
• Growing awareness of the defect and rising demand for the development of advanced diagnostic technology are key factors responsible to boost the market growth.
• High maintenance cost of installing treatment devices and lack of technical skills are projected to hamper the market growth
• Technological advancement and R&D activities to enhance existing treatment devices for ASD are expected to create opportunities for the market growth.

Scope of Atrial Septal Defect Market Report

The report on the global atrial septal defect market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Atrial Septal Defect Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Diagnosis (Chest X-ray, Electrocardiogram, Cardiac Catherization, Transesophageal echocardiography, and Pulse Oximetrey)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Asklepion Pharmaceuticals, LLC, Actelion Ltd, Novo Nordisk A/S, Abbott Laboratories, INO Therapeutics, St. Jude Medical, Occlutech, W. L. Gore & Associates, Boston Scientific Corp, SentreHEART, Coherex Medical, Starway, LifeTech, Lepu Medical Technology, MicroPort, Beijing Balance Medical Technology, Mallow medical, Visee Medical Devices, and Ya Tai Science & Technology

Atrial Septal Defect Market Segment Insights

Electrocardiogram segment is projected to hold a key market share

On the basis of diagnosis, the global atrial septal defect market is segmented into chest X-ray, electrocardiogram, cardiac catherization, transesophageal echocardiography (TEE), and pulse oximetrey. The electrocardiogram segment is expected to hold a key share of the market during the forecast period owing to advanced technologies and increase in accessibility to advanced treatments. Electrocardiogram (ECG) deals with recording electrical signal from heart of an individual and detecting heart problems. Rising occurrence of heart diseases across the globe is major factor responsible for driving the segment growth.

For diagnosis of ASD, chest X-ray test is widely used in order to detect the condition of lungs and heart. Transesophageal echocardiography (TEE) test provides ultrasound image, which gives clear image of the atria. Pulse oximetrey test is used to identify whether oxygenated blood is mixing with deoxygenated blood. Medications such as anti-platelet agents, beta blockers, and anticoagulants are also used to reduce signs and symptoms of ASD. In some serious and major conditions, surgery such as such as open-heart surgery and cardiac cauterization are used for repairing ASD. Meanwhile, the cardiac catherization test is adopted for diagnosis of any inborn heart defects examining the oxygen present in the blood. In this test, catheter is inserted into heat or though vein. The cardiac catherization segment is projected to grow owing to growing burden on neurology disorder, rising demand for antimicrobial catheters, and urology disorders.
 

Asia Pacific is expected to dominate the market

On the basis of regions, the global atrial septal defect market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to expand at an impressive CAGR during the forecast period. North America accounted for a major market share in 2020, which was followed by Europe. In these regions, there are some major factors such as high occurrence of genetic disorders and increasing awareness about arterial septal defects among people, which are responsible for the regional market growth. Use of advanced technology in treatment of congenital heart diseases is likely to fuel the regional market growth.

On the other hand, the market in Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to the presence of a large population base in the region. Moreover, presence of emerging economies focusing on the development of the healthcare infrastructure is expected to propel the regional market growth during the forecast period.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Atrial Septal Defect Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Atrial Septal Defect Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Atrial Septal Defect Market - Supply Chain
  4.5. Global Atrial Septal Defect Market Forecast
     4.5.1. Atrial Septal Defect Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Atrial Septal Defect Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Atrial Septal Defect Market Absolute $ Opportunity
5. Global Atrial Septal Defect Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Atrial Septal Defect Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Atrial Septal Defect Demand Share Forecast, 2019-2026
6. North America Atrial Septal Defect Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Atrial Septal Defect Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Atrial Septal Defect Demand Share Forecast, 2019-2026
7. Latin America Atrial Septal Defect Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Atrial Septal Defect Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Atrial Septal Defect Demand Share Forecast, 2019-2026
8. Europe Atrial Septal Defect Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Atrial Septal Defect Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Atrial Septal Defect Demand Share Forecast, 2019-2026
9. Asia Pacific Atrial Septal Defect Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Atrial Septal Defect Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Atrial Septal Defect Demand Share Forecast, 2019-2026
10. Middle East & Africa Atrial Septal Defect Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Atrial Septal Defect Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Atrial Septal Defect Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Atrial Septal Defect Market: Market Share Analysis
  11.2. Atrial Septal Defect Distributors and Customers
  11.3. Atrial Septal Defect Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Asklepion Pharmaceuticals
     11.4.2. LLC
     11.4.3. Actelion Ltd
     11.4.4. Novo Nordisk A/S
     11.4.5. Abbott Laboratories
     11.4.6. INO Therapeutics
     11.4.7. St. Jude Medical
     11.4.8. Occlutech
     11.4.9. W. L. Gore & Associates
     11.4.10. Boston Scientific Corp